STRATA Skin Sciences, Inc. (SSKN) EBIT Margin (2012 - 2025)
STRATA Skin Sciences (SSKN) posted EBIT Margin of 5.25% for Q4 2025, up 131.02% sequentially from 16.93% in Q3 2025, and up 5000.0% YoY from 0.1% in Q4 2024.
STRATA Skin Sciences, Inc. (SSKN) EBIT Margin (2012 - 2025) Analysis & Trends
STRATA Skin Sciences has reported EBIT Margin for 14 years, with the latest figure at 5.25% in Q4 2025.
- Quarterly EBIT Margin rose 5000.0% year-over-year to 5.25% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 15.31% (up 1226.0% YoY) and the FY2025 annual result came in at 15.31%, up 1226.0% from the prior year.
- EBIT Margin improved to 5.25% in Q4 2025 per SSKN's latest filing, from 16.93% in the prior quarter.
- Over five years, EBIT Margin peaked at 5.25% in Q4 2025 and troughed at 44.75% in Q4 2024.
- A 5-year average of 20.38% and a median of 18.43% in 2022 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2023 and 2025: EBIT Margin slumped 4087 bps in 2023, then surged 5000 bps in 2025.
- Over 5 years, EBIT Margin stood at 6.87% in 2021, then soared by 118 bps to 1.26% in 2022, then sank by 3233 bps to 39.6% in 2023, then dropped by 13 bps to 44.75% in 2024, then soared by 112 bps to 5.25% in 2025.
- According to Business Quant data, EBIT Margin over the past three periods registered 5.25%, 16.93%, and 30.14% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.25% |
| Sep 30, 2025 | -16.93% |
| Jun 30, 2025 | -30.14% |
| Mar 31, 2025 | -25.03% |
| Dec 31, 2024 | -44.75% |
| Sep 30, 2024 | -18.24% |
| Jun 30, 2024 | -5.67% |
| Mar 31, 2024 | -42.75% |
| Dec 31, 2023 | -39.60% |
| Sep 30, 2023 | -6.95% |
| Jun 30, 2023 | -23.78% |
| Mar 31, 2023 | -34.17% |
| Dec 31, 2022 | 1.26% |
| Sep 30, 2022 | -8.35% |
| Jun 30, 2022 | -18.61% |
| Mar 31, 2022 | -32.71% |
| Dec 31, 2021 | -6.87% |
| Sep 30, 2021 | -6.03% |
| Jun 30, 2021 | -12.50% |
| Mar 31, 2021 | -41.05% |